Cardioprotection encompasses a variety of strategies protecting the heart against
myocardial injury that occurs during and after inadequate blood supply to the heart during …

The aim of pharmacological conditioning is to protect the heart against myocardial ischemia-
reperfusion (I/R) injury and its consequences. There is extensive literature that reports a …

Nucleic acid-based therapeutics are currently developed at large scale for prevention and
management of cardiovascular diseases (CVDs), since:(i) genetic studies have highlighted …

The biological function of long noncoding RNA NEAT1 has been revealed in a lot of
diseases. Nevertheless, it is still not yet clear whether NEAT1 can modulate the process of …

Background Gamma-glutamyl transferase (GGT) has been shown to be involved in the
pathogenesis of both coronary artery disease (CAD) and liver disease, and it has been …

Reactive oxygen species (ROS) are a class of reactive molecules that have been implicated
in a variety of cardiovascular diseases, accompanied by disorder of multiple signaling …

Background Cardiovascular diseases are currently the leading cause of death in humans.
The high mortality of cardiac diseases is associated with myocardial ischemia and …

Acute heart attack is the primary cause of cardiovascular-related death worldwide. A
common treatment is reperfusion of ischemic tissue, which can cause irreversible damage to …

Approximately 2150 adults die every day in the US from Cardiovascular Diseases (CVD)
and another 115 deaths are attributed to opioid-related causes. Studies have found …

Breast cancer is the leading cause of mortality in women. It is a heterogeneous disease with
a high degree of inter-subject variability even in patients with the same type of tumor, with …